Cango Falls Below US$1 Average Share Price, NYSE Grants Six-Month Cure Period
Cango Inc. received a notice from the NYSE on March 10, 2026 that its Class A shares failed to maintain an average closing price of US$1.00 over 30 trading days as of March 9. The company has a six-month cure period to regain compliance or face suspension and delisting procedures.
1. NYSE Price Non-Compliance Notice
On March 10, 2026, Cango Inc. received a letter from the New York Stock Exchange notifying that its Class A ordinary shares had an average closing price below US$1.00 across 30 consecutive trading days ending March 9. This notice triggers NYSE continued listing standard Section 802.01C non-compliance procedures.
2. Six-Month Cure Period Details
Under Section 802.01C, Cango has a six-month Cure Period to achieve a US$1.00 closing share price and a minimum US$1.00 average closing price over the prior 30 trading days on the last business day of any month. Failure to meet both thresholds by the end of the period will prompt suspension and delisting procedures.
3. Potential Impact and Company Response
Cango stated it will monitor market conditions and explore options to restore its share price within the Cure Period. The listing notice does not affect ongoing mining operations, SEC reporting requirements or existing credit agreements while shares remain trading.